Suchergebnisse - "Yu, Ai-Ming"

PubPharm (197)

1

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

enthalten in: Nature communications | 2024

von Luo, Z. | Huang, Y. | Batra, N. | +15

2

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

enthalten in: Acta pharmaceutica Sinica. B | 2023

von Chen, Y. | Tu, M. | Han, F. | +6

3

Erratum : Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo' [Acta Pharmaceutica Sinica B 11 (2021) 3950-3965

enthalten in: Acta pharmaceutica Sinica. B | 2023

von Deng, L. | Petrek, H. | Tu, M. | +3

ErratumFor: Acta Pharm Sin B. 2021 Dec;11(12):3950-3965. - PMID 35024318

4

Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2023

von Cronin, J. | Yu, A.

5

ATR Inhibition in Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2023

von Leibrandt, R. | Tu, M. | Yu, A. | +2

6

Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition

enthalten in: Current drug metabolism | 2023

von Tu, M. | Yu, A.

7

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies

enthalten in: The Journal of pharmacology and experimental therapeutics | 2023

von Traber, G. | Yu, A.

8

Metabolic Flux Analysis Reveals the Roles of Stearate and Oleate on CPT1C-mediated Tumor Cell Senescence

enthalten in: International journal of biological sciences | 2023

von Chen, P. | Tian, J. | Zhou, Y. | +9

9

DNA-Thioguanine Nucleotides as a Marker for Thiopurine Induced Late Leukopenia after Dose Optimizing by NUDT15 C415T in Chinese Patients with IBD

enthalten in: Clinical pharmacology and therapeutics | 2022

von Zhu, X. | Chao, K. | Yang, T. | +12

10

Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment

enthalten in: Molecular cancer therapeutics | 2022

von Ning, S. | Liu, C. | Lou, W. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]